Analytical Data
-
基因名
CLEC2C
- Application
-
别名
CLEC2C；CLEC2C；Early activation antigen CD69
-
种属
Human
-
表达系统
E. coli
-
标签
His tag N-Terminus
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
Q07108
-
表达区间
62-199aa
-
氨基酸序列
SVGQYNCPG QYTFSMPSDS HVSSCSEDWV GYQRKCYFIS TVKRSWTSAQ NACSEHGATL AVIDSEKDMN FLKRYAGREE HWVGLKKEPG HPWKWSNGKE FNNWFNVTGS DKCVFLKNTE VSSMECEKNL YWICNKPYK
-
分子量
17 kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
CLEC2C, a member of the C-type lectin-like receptor family, plays a crucial role in immune responses and has garnered significant attention in recent research. It is primarily expressed on various immune cells, including dendritic cells and macrophages, and is involved in recognizing specific glycoproteins associated with pathogens. Recent studies have highlighted the importance of CLEC2C in mediating immune tolerance and regulation, making it a key player in both initiating and resolving immune responses. Its unique structure and ligand-binding properties suggest that it may interact with a range of endogenous and exogenous molecules, influencing diverse physiological processes. Researchers are increasingly focusing on CLEC2C's potential as a therapeutic target in autoimmune diseases, infections, and cancers, where modulation of immune responses could lead to improved clinical outcomes. Additionally, understanding its signaling pathways and interactions may provide insights into the development of novel immunotherapies. Given its significant implications in immunology, the continued exploration of CLEC2C will likely yield valuable information pertaining to immune system dynamics and therapeutic innovations.
